Hood River Capital Management »

Iovance Biotherapeutics shares owned by Hood River Capital Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Hood River Capital Management from 13F filings

Historical chart of Hood River Capital Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Hood River Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Hood River Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.1M 2.0M 4.55
2023-06-30 $14M 2.0M 7.04
2021-03-31 $15M 461k 31.66
2020-12-31 $24M 505k 46.40
2020-09-30 $16M 497k 32.92
2020-06-30 $15M 547k 27.45

More positions owned by Hood River Capital Management

Ftai Aviation Common Stocks (FTAI)
Rambus Common Stocks (RMBS)
Lantheus Holdings Common Stocks (LNTH)
Celsius Holdings Common Stocks (CELH)
Comfort Systems Usa Common Stocks (FIX)
Onto Innovation Common Stocks (ONTO)
Firstcash Holdings Common Stocks (FCFS)
Axonics Common Stocks (AXNX)
Clean Harbors Common Stocks (CLH)
Vertiv Holdings Common Stocks (VRT)
Kinsale Capital Group Common Stocks (KNSL)
Kirby Corp Common Stocks (KEX)
Axcelis Technologies Common Stocks (ACLS)
Select Medical Holdings Corp Common Stocks (SEM)
Krystal Biotech Common Stocks (KRYS)

View all positions for Hood River Capital Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
OrbiMed Advisors
Susquehanna International
Jpmorgan Chase & Co
Balyasny Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Dimensional Fund Advisors
Long Focus Capital Management
Palo Alto Investors
Caption Management

View all funds holding Iovance Biotherapeutics